JPWO2020028554A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020028554A5 JPWO2020028554A5 JP2021504826A JP2021504826A JPWO2020028554A5 JP WO2020028554 A5 JPWO2020028554 A5 JP WO2020028554A5 JP 2021504826 A JP2021504826 A JP 2021504826A JP 2021504826 A JP2021504826 A JP 2021504826A JP WO2020028554 A5 JPWO2020028554 A5 JP WO2020028554A5
- Authority
- JP
- Japan
- Prior art keywords
- trospium
- bladder
- pharmaceutical composition
- individual
- effective amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024121447A JP2024164020A (ja) | 2018-08-01 | 2024-07-26 | トロスピウムを使用した過活動膀胱の治療方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862713414P | 2018-08-01 | 2018-08-01 | |
| US62/713,414 | 2018-08-01 | ||
| US201962850481P | 2019-05-20 | 2019-05-20 | |
| US62/850,481 | 2019-05-20 | ||
| PCT/US2019/044478 WO2020028554A1 (en) | 2018-08-01 | 2019-07-31 | Methods of treating overactive bladder using trospium |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024121447A Division JP2024164020A (ja) | 2018-08-01 | 2024-07-26 | トロスピウムを使用した過活動膀胱の治療方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021532155A JP2021532155A (ja) | 2021-11-25 |
| JP2021532155A5 JP2021532155A5 (https=) | 2022-08-10 |
| JPWO2020028554A5 true JPWO2020028554A5 (https=) | 2022-08-10 |
Family
ID=69232612
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021504826A Pending JP2021532155A (ja) | 2018-08-01 | 2019-07-31 | トロスピウムを使用した過活動膀胱の治療方法 |
| JP2024121447A Pending JP2024164020A (ja) | 2018-08-01 | 2024-07-26 | トロスピウムを使用した過活動膀胱の治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024121447A Pending JP2024164020A (ja) | 2018-08-01 | 2024-07-26 | トロスピウムを使用した過活動膀胱の治療方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11464734B2 (https=) |
| EP (1) | EP3829582A4 (https=) |
| JP (2) | JP2021532155A (https=) |
| KR (1) | KR20210039403A (https=) |
| CN (1) | CN112839653A (https=) |
| AU (1) | AU2019315957A1 (https=) |
| BR (1) | BR112021001337A2 (https=) |
| CA (1) | CA3107461A1 (https=) |
| MX (1) | MX2021001264A (https=) |
| WO (1) | WO2020028554A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT4124339T (lt) | 2014-03-06 | 2025-11-10 | Vaisto įvedimo sistemos ir būdai šlapimo pūslės vėžiui gydyti gemcitabinu | |
| BR112020000832A2 (pt) | 2017-07-25 | 2020-07-21 | Taris Biomedical Llc | métodos para tratar metástase tumoral |
| JOP20200124A1 (ar) | 2017-11-08 | 2020-05-20 | Taris Biomedical Llc | طُرق لعلاج سرطان المثانة باستخدام جيمسيتابين وعلاج مدوامة لذلك |
| CN112839653A (zh) | 2018-08-01 | 2021-05-25 | 塔里斯生物医药公司 | 使用曲司氯铵治疗膀胱过度活动症的方法 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2125696T3 (es) * | 1996-11-27 | 1999-03-01 | Pfleger R Chem Fab | Utilizacion del cloruro de tropsio para la produccion de una preparacion farmaceutica para el tratamiento de disfunciones vesicales. |
| MX2013000002A (es) * | 2001-07-27 | 2013-04-29 | Teva Womens Health Inc | Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva. |
| US20060058777A1 (en) | 2002-12-11 | 2006-03-16 | Pia Norup Nielsen | Urinary catheter device with a pharmaceutically active composition |
| WO2004064789A2 (en) | 2003-01-16 | 2004-08-05 | University Of Rochester | Quaternary antimuscarinic compounds for the treatment of bladder diseases |
| EP1703895A2 (en) * | 2004-01-13 | 2006-09-27 | Vasogenix Pharmaceuticals, Inc. | Controlled release cgrp delivery composition for cardiovascular and renal indications |
| ES2322148T3 (es) | 2004-08-11 | 2009-06-17 | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG | Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias. |
| US20060128808A1 (en) | 2004-10-20 | 2006-06-15 | Galderma Research & Development, S.N.C. | Method of using adapalene in acne maintenance therapy |
| WO2006101954A2 (en) * | 2005-03-17 | 2006-09-28 | Indevus Pharmaceuticals, Inc. | Interstitial cystitis treatment |
| US7390816B2 (en) * | 2005-06-21 | 2008-06-24 | Bridge Pharma, Inc. | Methods for treating urinary incontinence in patients suffering from memory disorders |
| DK1933810T3 (da) | 2005-08-11 | 2013-01-28 | Childrens Medical Center | Intravesikal lægemiddelafgivelsesindretning og fremgangsmåde |
| ES2365161T3 (es) | 2005-09-02 | 2011-09-23 | Theravida, Inc. | Terapia para el tratamiento de la vejiga hiperactiva. |
| EP1967202A1 (en) | 2007-03-05 | 2008-09-10 | AEterna Zentaris GmbH | Use of LHRH Antagonists for the Treatment of Lower Urinary Tract Symptoms, in particular Overactive Bladder and/or Detrusor Overactivity |
| KR101538748B1 (ko) | 2007-12-11 | 2015-07-22 | 메사추세츠 인스티튜트 오브 테크놀로지 | 이식형 의약 투여 장치와 방광과 기타 신체 낭 또는 내강의 치료 방법 |
| EA201170297A1 (ru) | 2008-08-09 | 2011-08-30 | Массачусетс Инститьют Оф Текнолоджи | Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей |
| DK2445570T3 (da) | 2009-06-26 | 2013-02-25 | Taris Biomedical Inc | Implanterbare lægemiddelafgivelsesindretninger samt fremgangsmåder til deres fremstilling |
| US9017312B2 (en) | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
| PL3884988T3 (pl) | 2009-12-17 | 2025-09-08 | Taris Biomedical Llc | Urządzenie implantowalne z tolerancją wewnątrzpęcherzową |
| EP3795121A1 (en) | 2010-08-05 | 2021-03-24 | TARIS Biomedical LLC | Ureteral stent drug delivery device |
| WO2012048114A1 (en) | 2010-10-06 | 2012-04-12 | Taris Biomedical, Inc. | Time-selective bioresorbable or collapsible drug delivery systems and methods |
| JP2014503554A (ja) | 2011-01-10 | 2014-02-13 | タリス バイオメディカル，インコーポレイテッド | 膀胱痛及び刺激性排尿の持続的治療の使用のためのリドカインレジメン |
| EP2670398B1 (en) | 2011-02-04 | 2017-06-07 | TARIS Biomedical LLC | Implantable device for controlled release of low solubility drug |
| MX367070B (es) | 2012-08-31 | 2019-08-05 | Taris Biomedical Llc | Sistemas de administracion de farmaco y metodos para el tratamiento de la prostata. |
| SG11201501424SA (en) | 2012-08-31 | 2015-03-30 | Taris Biomedical Llc | Drug delivery systems and methods for treatment of bladder cancer comprising oxaliplatin |
| MX379066B (es) * | 2012-09-18 | 2025-03-04 | Taris Biomedical Llc | Sistemas de administracion de farmaco y metodos para el tratamiento de la disfuncion miccional de la vejiga y otros trastornos del tracto urinario inferior. |
| EP2719374A1 (en) * | 2012-10-12 | 2014-04-16 | Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen | Drug delivery device |
| JP2016508842A (ja) | 2013-03-05 | 2016-03-24 | タリス バイオメディカル エルエルシー | 装置の開口部を通じて制御された薬物放出のための薬物送達装置及び方法 |
| EP2968120B1 (en) | 2013-03-15 | 2026-01-14 | TARIS Biomedical LLC | Drug delivery devices and methods for drug delivery |
| KR102557326B1 (ko) | 2013-03-15 | 2023-07-19 | 타리스 바이오메디컬 엘엘씨 | 약물-투과성 구성요소를 가지는 약물 전달 장치 |
| KR102385603B1 (ko) | 2013-08-19 | 2022-04-11 | 타리스 바이오메디컬 엘엘씨 | 다중 유닛 약물 전달 장치 및 방법 |
| EP3065807A1 (en) | 2013-11-05 | 2016-09-14 | TARIS Biomedical LLC | Osmotic drug delivery devices, kits, and methods |
| LT4124339T (lt) | 2014-03-06 | 2025-11-10 | Vaisto įvedimo sistemos ir būdai šlapimo pūslės vėžiui gydyti gemcitabinu | |
| KR20220061253A (ko) | 2014-06-26 | 2022-05-12 | 타리스 바이오메디컬 엘엘씨 | 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법 |
| WO2016172704A1 (en) | 2015-04-23 | 2016-10-27 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
| US20190060407A1 (en) * | 2015-09-10 | 2019-02-28 | Assistance Publique - Hôpitaux De Paris | Use of interleukin 2 for treating spondyloarthritis |
| JP6283440B1 (ja) * | 2016-10-27 | 2018-02-21 | Ｅａファーマ株式会社 | 逆流性食道炎の再発抑制剤 |
| PT3432970T (pt) * | 2017-02-01 | 2021-05-26 | Taris Biomedical Llc | Dispositivos de administração de fármaco in vivo |
| BR112020000832A2 (pt) | 2017-07-25 | 2020-07-21 | Taris Biomedical Llc | métodos para tratar metástase tumoral |
| CN112839653A (zh) | 2018-08-01 | 2021-05-25 | 塔里斯生物医药公司 | 使用曲司氯铵治疗膀胱过度活动症的方法 |
-
2019
- 2019-07-31 CN CN201980064872.5A patent/CN112839653A/zh active Pending
- 2019-07-31 AU AU2019315957A patent/AU2019315957A1/en not_active Abandoned
- 2019-07-31 BR BR112021001337-7A patent/BR112021001337A2/pt unknown
- 2019-07-31 WO PCT/US2019/044478 patent/WO2020028554A1/en not_active Ceased
- 2019-07-31 EP EP19844186.7A patent/EP3829582A4/en active Pending
- 2019-07-31 CA CA3107461A patent/CA3107461A1/en active Pending
- 2019-07-31 KR KR1020217005331A patent/KR20210039403A/ko not_active Ceased
- 2019-07-31 MX MX2021001264A patent/MX2021001264A/es unknown
- 2019-07-31 JP JP2021504826A patent/JP2021532155A/ja active Pending
- 2019-07-31 US US16/528,032 patent/US11464734B2/en active Active
-
2022
- 2022-08-11 US US17/886,325 patent/US12133913B2/en active Active
-
2024
- 2024-07-26 JP JP2024121447A patent/JP2024164020A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021532155A5 (https=) | ||
| Foster et al. | Efficacy and safety of rimexolone 1% ophthalmic suspension vs 1% prednisolone acetate in the treatment of uveitis | |
| JP2018514540A (ja) | 点頭てんかん治療へのカンナビジオールの使用 | |
| CN108884053B (zh) | 预防和/或治疗与衰老有关的认知障碍和神经炎症的方法 | |
| CN1829532A (zh) | 肌肉抑制素（gdf8）抑制剂和皮质类固醇联合用于治疗神经肌肉紊乱的用途 | |
| HK1211216A1 (en) | Non-irritating ophthalmic povidone-iodine compositions | |
| EP3015107B1 (en) | Agent for treating meibomian gland dysfunction | |
| WO2007067807B1 (en) | Tetracyclines for treating ocular diseases and disorders | |
| JPWO2020028554A5 (https=) | ||
| US9149509B2 (en) | Methods for improving neurological outcome after neural injury and neurodegenerative disease | |
| CA2772174A1 (fr) | Medicament inhalable a base de xenon pour traiter ou pour prevenir les dyskinesies induites | |
| US11351229B2 (en) | Combination therapies for treating infantile spasms and other treatment resistant epilepsies | |
| Chavis et al. | Cyclosporine effects on optic nerve and retinal vasculitis in Behçet's disease | |
| US10548870B2 (en) | Method for treating multiple sclerosis | |
| CN117959307A (zh) | 利马前列素的医药用途 | |
| CN1290166A (zh) | 运动障碍的治疗 | |
| CN120284871B (zh) | 用于鼻腔的含奥洛他定与溴莫尼定的复方制剂组合物及其制备方法 | |
| Donohoe et al. | Motor neuron disease: Etiology, pathogenesis and treatment—A review | |
| EP4656198A2 (en) | Use of gmi from ganoderma lucidum spores in the preparation of pharmaceuticals and food products | |
| RU2021104894A (ru) | Способы лечения гиперактивного мочевого пузыря с применением троспия хлорида | |
| RU2816583C1 (ru) | Применение пептида формулы met-glu-his-phe-pro-gly-pro для лечения аносмии при covid-19 | |
| JP2024517025A (ja) | 乾癬の治療のための方法 | |
| CN120361195A (zh) | 一种治疗外阴硬化性苔藓的外用药物组合物及其制备方法及外阴面膜敷料 | |
| CN115569186A (zh) | 一种包含催产素的用于治疗干眼症的药物组合物 | |
| JPWO2021046448A5 (https=) |